BioLife Solutions Inc BLFS Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-29,182

Price:

$41.03
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-40,000

Price:

$40.30
Jan 15, 2021 (filed on Jan 19, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-29,338

Price:

$40.62
Jan 14, 2021 (filed on Jan 19, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-22,152

Price:

$43.08
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,435

Price:

$40.40
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-12,723

Price:

$40.13
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-27,277

Price:

$40.35
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-40,000

Price:

$40.20
Jan 08, 2021 (filed on Jan 13, 2021)

Insider Name:

Schulz Marcus

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-293

Price:

$39.01
Jan 07, 2021 (filed on Jan 08, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-30,000

Price:

$39.55

Filings by filing date

Jan 20, 2021 (filed on Jan 21, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-29,182

Price:

$41.03
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-40,000

Price:

$40.30
Jan 15, 2021 (filed on Jan 19, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-29,338

Price:

$40.62
Jan 14, 2021 (filed on Jan 19, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-22,152

Price:

$43.08
Jan 08, 2021 (filed on Jan 13, 2021)

Insider Name:

Schulz Marcus

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-293

Price:

$39.01
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,435

Price:

$40.40
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-12,723

Price:

$40.13
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-27,277

Price:

$40.35
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-40,000

Price:

$40.20
Jan 07, 2021 (filed on Jan 08, 2021)

Insider Name:

Villiger Walter

Ownership Type:

Indirect Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-30,000

Price:

$39.55

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	3303 Monte Villa Pkwy Ste 310 BOTHELL WA 98021-6200
Tel:	1-425-4021400
Website:	https://biolifesolutions.com
IR:	See website

Key People

Raymond Wayne Cohen Independent Chairman of the Board	Michael Rice President, Chief Executive Officer, Director	Roderick de Greef Chief Financial Officer, Chief Operating Officer, Secretary, IR Contact Officer
Aby J. Mathew Executive Vice President and Chief Scientific Officer	Todd Berard Chief Marketing Officer	Marcus Schulz Vice President, Global Sales
Sarah Aebersold Vice President - Global Human Resources	Karen A. Foster Chief Quality Officer

Business Overview

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Financial Overview

For the nine months ended 30 September 2020, BioLifeSolutions Inc revenues increased 75% to $33.4M. Net incometotaled $4.8M vs. loss of $4.6M. Revenues reflect Productrevenue increase of 69% to $32M, Rental revenue increasefrom $182K to $1.3M. Net Income reflects Change in fairvalue of warrant liabilit increase from $14.9M (expense) to$4.5M (income), Change in fair value of contingent consiincrease from $0K to $1.5M (income).

Employees:	151 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$1,305M as of Sep 30, 2020
Annual revenue (TTM):	$41.66M as of Sep 30, 2020
EBITDA (TTM):	$3.93M as of Sep 30, 2020
Net annual income (TTM):	-$7.44M as of Sep 30, 2020
Free cash flow (TTM):	-$0.30M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	32,735,912 as of Nov 6, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

BioLife Solutions Inc (OQ:BLFS)